MedTrace Logo

COMPASS: a Comprehensive Mobile Precision Approach for Scalable Solutions in Mental Health Treatment

NCT06840457 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4400

Last updated 2025-02-21

No results posted yet for this study

Summary

This research study is being conducted to understand if patients benefit from mobile health interventions while waiting for in-clinic mental health treatments.

Conditions

Interventions

BEHAVIORAL

Mindfulness + Tailored Messages

Tailored Messages (TM) Participants randomized to receive enhanced feedback will receive this feedback from the MyDataHelps study app. This includes varying types of text and visual feedback based on data collected through the app. Messages will be displayed to participants on a dashboard in the app or delivered via pop-up notifications. Participants will receive a combination of text and visual messages. The study will use an app designed to train the user in mindfulness practices.

BEHAVIORAL

Mindfulness without Tailored Messages

The study will use an app designed to train the user in mindfulness practices.

BEHAVIORAL

Cognitive Behavioral Therapy (CBT) + Tailored Messages

Tailored Messages (TM) Participants randomized to receive enhanced feedback will receive this feedback from the MyDataHelps study app. This includes varying types of text and visual feedback based on data collected through the app. Messages will be displayed to participants on a dashboard in the app or delivered via pop-up notifications. Participants will receive a combination of text and visual messages. The study will use an app designed to deliver cognitive behavioral therapy.

BEHAVIORAL

Cognitive Behavioral Therapy (CBT) without Tailored Messages

The study will use an app designed to deliver cognitive behavioral therapy.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-03
Primary Completion
2028-09-30
Completion
2029-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06840457 on ClinicalTrials.gov